Antibiotic Resistance and Molecular Epidemiology of Vancomycin-Resistant Enterococci in a Tertiary Care Hospital in Turkey

Figures & data

Table 1 Demographic and Clinical Features of Patients with VRE^a (n = 47)

Data	Number (%)
Age (years)
40–59	5 (10.6)
60–79	25 (53.2)
≥80	17 (36.2)
Gender
Female	26 (55.3)
Male	21 (44.7)
Hospital unit
Intensive care unit (ICU)	38 (80.9)
Reanimation ICU	20 (42.6)
Surgical ICU	14 (29.8)
Respiratory ICU	4(8.5)
Wards	9 (19.1)
General surgery	5 (10.6)
Urology	4 (8.5)
Underlying diseases
Cerebrovascular disease	23 (48.9)
COPD^b	20 (42.6)
Renal failure	15 (31.9)
Hypertension	8 (17.0)
Malignancy	8 (17.0)
Heart failure	6 (12.8)
Diabetes mellitus	4 (8.5)
Comorbidities/risk factors
Intubation	28 (59.6)
Central venous catheterization	26 (55.3)
Peripheral arterial catheterization	19 (40.4)
Hemodialysis	13 (27.7)
Unconsciousness	12 (25.5)
Total parenteral nutrition	12 (25.5)
Nasogastric intubation	10 (21.3)
CPR (cardiopulmonary resuscitation)	8 (17.0)
Blood transfusion	8 (17.0)
Steroid usage	5 (10.6)

Notes: ^aVancomycin-resistant Enterococcus. ^bChronic obstructive pulmonary disease.

Figure 1 Dendrogram based on pulsed-field gel electrophoresis pattern analysis of the VRE strains. The distribution of PFGE types among VRE strains and other demographic data (specimen, isolation date, and wards) are presented. The PFGE genotypes of VRE strains were named with Roman numerals (I–VII).

Abbreviations: RS, rectal swab; ICU, intensive care unit.